Prostate GU011
Study #GU011A Phase II Double-Blind, Placebo-Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)
Back To Clinical Trials NCI Database Entry